SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Sunshine Biopharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.24+0.02 (+9.02%)
Close on Oct 19, 2026
- Market cap
- $330.14K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Sunshine Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 13, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2026 | Aug 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2026 | Jul 10, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2026 | Apr 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 3, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 11, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 3, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 2, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 23, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 10, 2024 | Oct 17, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2024 | Sep 10, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Jun 30, 2024 | Aug 20, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2024 | Aug 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 16, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 28, 2024 | Jul 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 28, 2024 | Jul 1, 2024 | SEC EDGAR |